56 results on '"Dietel, M"'
Search Results
2. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
3. Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
4. OA05 Tumor Mutational Burden Standardization Initiative: Establish a Consistent Methodology for TMB Measurement in Clinical Samples
5. Tumor mutational burden (TMB) standardization initiative: Establishing a consistent methodology for TMB measurement in clinical samples
6. RNA-based analysis of anaplastic lymphoma kinase (ALK) fusions in non-small cell lung cancer (NSCLC) cases showing immunohistochemistry/fluorescence in-situ hybridisation (IHC/FISH) discordance
7. PD.1.02 Real-World Prevalence of PD-L1 Expression in Advanced Non–Small-Cell Lung Cancer: The Global, Multicenter EXPRESS Study
8. 130O Real-world prevalence of PD-L1 expression in locally advanced or metastatic non-small cell lung cancer (NSCLC): The global, multicentre EXPRESS study
9. Corrections to “SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study”
10. ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?
11. 2776 Cancer testis antigen Cyclin A1 is broadly expressed in ovarian cancer and associated with prolonged time to progression after platinum-based chemotherapy
12. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition
13. SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
14. E11. Quality assurance and breast cancer pathology
15. Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
16. A Novel Multigene Assay in Clinical Practice - Performance and Impact On Clinical Decisions
17. RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
18. Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer (NSCLC): Results of the First Intern Round Robin Panel Testing (8 Institutes from Germany and SWITZERLAND)
19. Detection of Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer (NSCLC): A Glance at “Borderline” Cases
20. Results of the Second Pilot External Quality Assurance Scheme for Somatic Egfr Mutation Testing in Non-Small-Cell Lung Cancer (NSCLC)
21. 48P Comparison of an Rna-Based Multigene Test Between Core Biopsies and Corresponding Surgical Breast Cancer Sections
22. 9144 POSTER EGFR Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status – Results From a German Registry
23. 9015 POSTER DISCUSSION EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany -Initial Results From a German Registry
24. Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOP
25. Quality indicators in breast cancer care
26. 785 SLC45A3 IS A COMMON ETS FAMILY FUSION PARTNER IN PROSTATE CANCER
27. Endoscopy of Barrett's Esophagus Guided By Fluorescence Imaging Using An Overlay Imaging Technique
28. 503 POSTER Comparative analysis of microarray testing and immunohistochemistry in patients with carcinoma of unknown primary – CUP syndrome
29. 350 POSTER Chass I histone deacetylase isoforms in prostate cancer: expression patterns in vivo and functional implications in vitro
30. Concordance of HER-2/neu expression of primary breast carcinomas and their metachronous distant metastases: results of a 10 year retrospective search in two university institutes of pathology
31. From virtual slides to virtual pathology institution: the future of tissue-based diagnosis?
32. Expression of gelsolin in ovarian carcinomas
33. Teleconsultation in diagnostic pathology: comparison of UICC-TPCC and iPATH servers using diagnosis-related scores
34. CD59 expression in prostate cancer: a new marker of disease progression?
35. Expression of the ELAV-like protein HuR in ovarian carcinoma
36. Differentially expressed genes in prostate cancer — identification of CD24 as a new prognostic marker
37. 339 Steroid administration prior to partial hepatectomy with temporary inflow occlusion does not influence cyclin D1 and Kl-67 related liver regeneration
38. Cytomegalovirus associated with progression and metastasis of colorectal cancer?
39. Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer
40. Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines
41. Evaluation of drug resistance mechanisms in mast cell leukemia
42. Drug resistance mechanisms in EBV-associated multiple myeloma as posttransplantation lymphoproliferative disorder
43. Angiomyxoma of the Umbilical Cord in One Twin with Cystic Degeneration of Wharton's Jelly. A Case Report
44. CGH patterns in head and neck squamous cell carcinomas
45. Distinct patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung
46. Subcutaneous Crystal-Storing Histiocytosis Associated with Lymphoplasmacytic Lymphoma (Immunocytoma)
47. Book Review
48. Book Review
49. Book Reviews
50. Book review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.